Nuveen’s Pfizer PFE Stock Holding History

Nuveen’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-26,350	Closed	-$1K	–	3336
2020 Q2	$1K	Buy	+26,350	New	+$895K	﹤0.01%	3263
2016 Q1	–	Sell	-5,270	Closed	-$161K	–	1473
2015 Q4	$161K	Sell	5,270 -6,324	-55%	-$199K	﹤0.01%	1458
2015 Q3	$346K	Hold	11,594	–	–	﹤0.01%	1395
2015 Q2	$369K	Sell	11,594 -10,540	-48%	-$344K	﹤0.01%	1433
2015 Q1	$731K	Sell	22,134 -54,808	-71%	-$1.74M	﹤0.01%	1270
2014 Q4	$2.27M	Buy	76,942 +1,054	+1%	+$30.2K	0.01%	790
2014 Q3	$2.13M	Hold	75,888	–	–	0.01%	798
2014 Q2	$2.14M	Buy	75,888 +2,108	+3%	+$60.1K	0.01%	795
2014 Q1	$2.25M	Sell	73,780 -36,890	-33%	-$1.1M	0.01%	761
2013 Q4	$3.22M	Sell	110,670 -18,972	-15%	-$552K	0.02%	617
2013 Q3	$4.02M	Sell	129,642 -35,836	-22%	-$975K	0.03%	574
2013 Q2	$4.4M	Buy	+165,478	New	+$4.57M	0.03%	542

Other funds holding PFE

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Nuveen's PFE Position: Q3 2026 in Review

Nuveen increased its Pfizer (PFE) stake by 2.2% in Q3 2026, buying an estimated $8.28M and bringing the position to 14,757,275 shares worth $421M. The position accounts for 0.1% of the portfolio, ranked #148.

Nuveen first reported a position in PFE in Q2 2013 and has held it in 54 quarters since. The position peaked at $1.66B in Q4 2021. 2,475 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Nuveen held 14,757,275 shares of Pfizer worth $421M as of Q3 2026.
Nuveen bought 311,488 Pfizer shares in Q3 2026, an estimated $8.28M.
Pfizer made up 0.1% of Nuveen's portfolio in Q3 2026, its #148 holding.
Nuveen first reported a position in Pfizer in Q2 2013 and has held it in 54 quarters since.
Nuveen's Pfizer position peaked at $1.66B in Q4 2021.
2,475 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.